Virginia Marcia Concato-Lopes

Virginia Marcia Concato-Lopes

Auto-generated profile, based on publicly available information

Virginia Marcia Concato-Lopes

Laboratory of Immunoparasitology of Neglected Diseases and Cancer, State University of Londrina, PR, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
VCVirginia Marcia Concato
Virginia Marcia Concato
FTFernanda Tomiotto-Pellissier
Fernanda Tomiotto-Pellissier
TSTaylon Felipe Silva
Taylon Felipe Silva
MGManoela Daiele Gonçalves
Manoela Daiele Gonçalves
BBBruna Taciane da Silva Bortoleti
Bruna Taciane da Silva Bortoleti
‪Wander R. Pavanelli‪Wander R. Pavanelli
‪Wander R. Pavanelli

1 May 2022 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
Tatiane Renata FagundesTatiane Renata Fagundes
Tatiane Renata Fagundes
BBBruna Taciane da Silva Bortoleti
Bruna Taciane da Silva Bortoleti
PCPriscila Goes Camargo
Priscila Goes Camargo
VCVírgínia Concato
Vírgínia Concato
FTFernanda Tomiotto-Pellissier
Fernanda Tomiotto-Pellissier
‪Wander R. Pavanelli‪Wander R. Pavanelli
‪Wander R. Pavanelli
Background: Conventional therapies for breast cancer are still a challenge due to cytotoxic drugs not being highly effective with significant adverse effects. Thiohydantoins are biologically active heterocyclic compounds reported for several biological activities, including anticarcinogenic properties, etc. This work aims to assess the use of thiohydantoin as a potential antitumor agent against MCF-7 breast cancer cells. Methods: MTT and neutral red assays were used to assess the possible cytotoxic activity of compounds against MCF-7 cells. Cell volume measurement and analysis were performed by flow cytometry. Fluorescence analysis was carried out to determine patterns of cell death induced by thiohydantoins. Results: The treatment with micromolar doses of thiohydantoins promoted a decrease in the viability of MCF-7 breast tumor cells. An increase in the ROS and NO production, reduction in cell volume, loss of membrane integrity, mitochondrial depolarization, and increased fluorescence for annexin-V and caspase-3 were also observed. These findings indicate cell death by apoptosis and increased autophagic vacuoles, stopping the cell cycle in the G1/ G0 phase. Conclusions: Our results indicate that thiohydantoins are cytotoxic to breast tumor cells, and this effect is linked to the increase in ROS production. This phenomenon changes tumorigenic pathways, which halt the cell cycle in G1/G0. This is an essential checkpoint for DNA errors, which may have altered how cells produce energy, causing a decrease in mitochondrial viability and thus leading to the apoptotic process. Furthermore, the results indicate increased autophagy, a vital process linked to a decrease in lysosomal viability and thus considered a cell death and tumor suppression mechanism.

24 April 2025 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
FIFabricio Seidy Ribeiro Inoue
Fabricio Seidy Ribeiro Inoue
VCVirginia Marcia Concato-Lopes
Virginia Marcia Concato-Lopes
BBBruna Taciane da Silva Bortoleti
Bruna Taciane da Silva Bortoleti
ECEllen Mayara Souza Cruz
Ellen Mayara Souza Cruz
MDMariana Barbosa Detoni
Mariana Barbosa Detoni
WPWander Rogério Pavanelli
Wander Rogério Pavanelli
Hepatocellular carcinoma (HCC) is a highly aggressive malignancy with frequent recurrence and chemoresistance, underscoring the need for new treatment strategies. 3,3',5,5'-Tetramethoxybiphenyl-4,4'-diol (TMBP) showed cytotoxicity against lung cancer cell lines without harming normal cells. Thus, we investigated the antitumoral effect of TMBP on HCC cell lines, HuH7.5 (p53-mutant) and HepG2/C3A (p53-wild type). Cells were treated with TMBP (12.5-150 µM) for 24 and 48 h, and metabolic cellular activity (MTT) were used to determine the 50 % inhibitory concentration (IC50) values. TMBP cytotoxicity were assessed by Trypan blue assay, scanning and transmission electron microscopy. Cell migration (wound healing), total ROS (H2DCFDA), mitochondrial dysfunction (TMRE), lipid droplets (Nile Red), and autophagic vacuoles (MDC) were assessed. Flow cytometry characterized cell cycle distribution and cell death. Caspase 3/7 activity and CASP3 expression confirmed apoptosis. Molecular docking and gene expression analysis validated TMBP-CDK1 interaction. TMBP reduced cell viability, with IC50 values of 68 and 55 µM (HuH7.5) and 50 and 42 µM (HepG2/C3A) at 24 and 48 h. TMBP induced severe morphological alterations, impaired migration, increased ROS, mitochondrial dysfunction, increased lipid droplets and autophagic vacuoles. TMBP also led to G2/M arrest and apoptosis, likely via CDK1 inhibition through hydrogen bonding at Tyr15. These findings highlight TMBP as a promising therapeutic candidate targeting CDK1 in HCC.

1 January 2024 in Brazilian Journal of Biology
Verified
Journal Article
Open access
PDF file
IVI. Vendruscolo
I. Vendruscolo
GBG. H. Berton
G. H. Berton
MBM. T. Biffi
M. T. Biffi
PBP. A. Bressiani
P. A. Bressiani
AOA. K. G. Oliveira
A. K. G. Oliveira
EDElisângela Düsman
Elisângela Düsman
Studies show that propolis has antimicrobial, antifungal, antiviral, anti-inflammatory, antioxidant, antitumor, and immunomodulatory properties, and may protect against diseases such as diabetes, cardiovascular disease, and cancer. We aimed to extract compounds of brown propolis with hydroalcoholic solvents and evaluate their cytotoxic activity on tumor and non-tumor cells by MTT test. We tested the solute:solvent ratio (ethanol:water) and extraction time in a Shaker incubator (710 rpm) before conducting a central composite rotational design (CCRD) to optimize time and solvent mixture. We found that a temperature of 80 °C and a solvent concentration of 90:10 were the best extraction conditions for phenolic compounds, especially pinocembrin and cinnamic acid. The extract showed antioxidant capacity, acid characteristics, low humidity, and the presence of ash, lipids, and soluble solids. The cytotoxicity test with normal kidney cells of Macaca mullata (LLC-MK2) and human lung tumor cells (A549) showed no statistical difference from the negative control. For liver tumor cells (HuH7.5), different concentrations showed cytotoxic/antiproliferative activity. Thus, the data indicate that this product deserves prominence in the search for new applications.

25 October 2026 in Advanced Science
Verified
Journal Article
Open access
TSTaylon Felipe Silva
Taylon Felipe Silva
VCVirginia Marcia Concato‐Lopes
Virginia Marcia Concato‐Lopes
FBFatima Bedier
Fatima Bedier
Lauren A NewmanLauren A Newman
Lauren A Newman
DKDiana Kitka
Diana Kitka
DVDolores Di Vizio
Dolores Di Vizio
Bone metastasis can be facilitated by systemic remodeling, yet the tumor‐derived signals that influence the bone marrow microenvironment remain incompletely understood. Large oncosomes (LOs) are atypically large (> 1 µm), tumor‐derived extracellular vesicles shed by amoeboid cancer cells. Here, we demonstrate that LOs function as systemic mediators of metastatic niche formation by activating innate immune sensing in bone marrow mesenchymal stem cells (BM‐MSCs). Systemic administration of LOs to immunocompetent tumor‐bearing mice did not affect primary tumor growth but increased metastatic burden. LOs induced a robust, dose‐dependent interferon‐driven inflammatory program, characterized by interferon‐stimulated genes and neutrophil chemokines. Mechanistically, this response was driven by LO‐associated nucleic acids activating convergent cytosolic DNA‐ and RNA‐sensing pathways in recipient stromal cells. LO‐conditioned BM‐MSCs promoted the accumulation and polarization of neutrophils toward an immunosuppressive, polymorphonuclear myeloid‐derived suppressor cell (PMN‐MDSC)‐like phenotype. In vivo, genetic suppression of LO shedding in tumor cells reduced PMN‐MDSC accumulation in the bone marrow, which was reversed by systemic LO administration. Together, these findings support a model in which LO‐associated signals reprogram the bone marrow microenvironment to support metastatic colonization, identifying a previously unrecognized mechanism linking tumor vesiculation to immune remodeling at distant sites.